Sentinel lymph node investigation in melanoma: Detailed analysis of the yield from step sectioning and immunohistochemistry

Journal of Clinical Pathology

Volumn 57, Issue 6, 2004, Pages 618-620

  Gietema, H A ^a   Vuylsteke, R J C L M ^a   De Jonge, I A ^a   Van Leeuwen, P A M ^a   Molenkemp, B G ^a   Van Der Sijp, J R M ^a   Meijer, S ^a   Van Diest, P J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL PROTOCOL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TISSUE SECTION;

ADULT; AGED; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MELANOMA; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 2642525224     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.011742     Document Type: Article

References (17)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
2. Statius Muller MG, van Leeuwen PAM, de Lange-De Klerk ES, et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 2001;91:2401-8.
3. Veen H, van der Hoekstra OS, Paul MA, et al. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994;81:1769-70.
4. Bachter D, Michl C, Buchels H, et al. The predictive value of the sentinel lymph node in malignant melanomas. Recent Results Cancer Res 2001;158:129-36.
5. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-83.
6. Jansen L, Nieweg OE, Peterse JL, et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 2000;87:484-9.
7. Statius Muller MG, Borgstein PJ, Pijpers R, et al. Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol 2000;7:461-8.
8. Roberts AA, Cochran AJ. Current management of sentinel lymph nodes: perspectives from pathology. Curr Diagn Pathol 2003;9:199-210.
9. Torrenga H, Rahusen FD, Meijer S, et al. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001;54:550-2.
10. van Diest PJ. Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol 1999;52:871-3.
11. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-60.
12. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67.
13. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999;86:617-27.
14. Cook MG, Green MA, Anderson B, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003;200:314-19.
15. Cserni G. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 2002;55:926-31.
16. Dowlatshahi K, Fan M, Bloom KJ, et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 1999;86:990-6.
17. Turner RR, Ollila DW, Krasne DL, et al. Histopothologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-6.